cl[Nical Study of Succide Among Patient With Psychoactive Substance Use Disorders
NCT05107180 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-11-10
Summary
detect risk of suicide among patient with substance use disorder
Conditions
Interventions
- DIAGNOSTIC_TEST
-
drug screen
urine sample
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-12-31
- Primary Completion
- 2021-12-31
- Completion
- 2023-12-31
More Related Trials
-
Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings
NCT02893514 ·Status: COMPLETED ·Phase: NA
-
A Setting Focus Overdose Prevention Intervention
NCT05320835 ·Status: RECRUITING ·Phase: NA
-
Addressing Overdose Risk Among Recently Incarcerated People Living With HIV/AIDS
NCT03569592 ·Status: COMPLETED ·Phase: NA
-
Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial
NCT05245513 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Drug Discrimination in Methadone-Maintained Humans Study 2
NCT00733239 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
NCT00000211 ·Status: COMPLETED ·Phase: PHASE2
-
Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
NCT06089707 ·Status: RECRUITING ·Phase: PHASE3
-
Contingency Management for Opioid and Stimulant Use Disorders in Primary Care
NCT05288751 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
NCT04939012 ·Status: RECRUITING ·Phase: NA
-
Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder: Supplement to COMPUTE 2.0
NCT04939727 ·Status: COMPLETED ·Phase: NA
-
Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)
NCT05776823 ·Status: COMPLETED ·Phase: NA
-
Preventing Opioid Overdose Mortality in the United States
NCT03924505 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity of Hepatitis B Vaccination Among Drug Users
NCT02959775 ·Status: COMPLETED ·Phase: PHASE4
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
NCT03135886 ·Status: RECRUITING ·Phase: NA
-
Clinician-patient Interaction During Addiction Consultation
NCT01769651 ·Status: UNKNOWN
-
A Electronic System to Improve Recovery Outcomes in Patients With Drug Use Disorder
NCT03451344 ·Status: COMPLETED ·Phase: NA
-
Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections
NCT04677114 ·Status: COMPLETED ·Phase: PHASE2
-
Using mHealth to Aid Opioid Addicts
NCT01955902 ·Status: COMPLETED
-
Risks and Benefits of Naloxone Prescribing
NCT02535494 ·Status: COMPLETED ·Phase: NA
-
Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients
NCT00295308 ·Status: COMPLETED ·Phase: PHASE1
-
Testing of the Integrated Rapid Access to HIV Prevention Program for People Who Inject Drugs Program
NCT04531670 ·Status: COMPLETED ·Phase: NA
-
Hair Testing to Assess Consumption of Illicit Psychotropic Agents and Alcohol by Patients Treated With High-dose Buprenorphine and Methadone. Search for a Pharmacogenetic Contribution to Low Efficacy of Substitution Medications
NCT01285856 ·Status: UNKNOWN ·Phase: NA
-
Social Network Overdose Prevention and Education Intervention
NCT06327061 ·Status: RECRUITING ·Phase: NA
-
Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone
NCT01637922 ·Status: COMPLETED ·Phase: PHASE1
-
SafetyNet Program for Opioid Use Disorder (OUD)
NCT04253782 ·Status: COMPLETED ·Phase: NA